RCUS

Arcus Bioscience

• TipRanks·04/02 13:12

  Wedbush raises Arcus Biosciences price target to $41, adds to Best Ideas List

• Dow Jones·04/02 13:09

  Arcus Biosciences Is Maintained at Outperform by Wedbush

• Dow Jones·04/02 13:09

  Arcus Biosciences Price Target Raised to $41.00/Share From $37.00 by Wedbush

• Benzinga·04/02 13:00

  Wedbush Maintains Outperform on Arcus Biosciences, Raises Price Target to $41

• Simply Wall St·03/27 23:07

  Assessing Arcus Biosciences (RCUS) Valuation After Recent Share Price Weakness And Strong One Year Rebound

• TipRanks·03/24 15:25

  Mizuho Securities Remains a Buy on Arcus Biosciences (RCUS)

• Dow Jones·03/23 12:37

  Damora Therapeutics Names Jennifer Jarrett as CEO

• TipRanks·03/23 12:24

  Arcus Biosciences Announces COO Resignation and Transition Plan

• TipRanks·03/23 12:15

  Damora Therapeutics appoints Jennifer Jarrett as CEO

• Simply Wall St·03/11 00:37

  Why Arcus Biosciences (RCUS) Is Up 9.5% After New Casdatifan Data And Pipeline Expansion

• Simply Wall St·03/09 08:12

  Arcus Biosciences (RCUS) Valuation After Casdatifan Kidney Cancer Data Pipeline Update And Earnings

• Simply Wall St·03/06 02:34

  Arcus Biosciences Casdatifan Data Reshapes Kidney Cancer And Valuation Story

• Dow Jones·03/05 19:43

  Arcus Biosciences Price Target Raised to $45.00/Share From $44.00 by Citigroup

• Dow Jones·03/05 19:43

  Arcus Biosciences Is Maintained at Buy by Citigroup

• Benzinga·03/05 19:34

  Citigroup Maintains Buy on Arcus Biosciences, Raises Price Target to $45